National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus

被引:0
作者
Jisu Kim
Susin Park
Hyunsoo Kim
Nam Kyung Je
机构
[1] Pusan National University,College of Pharmacy
来源
European Journal of Clinical Pharmacology | 2019年 / 75卷
关键词
Diabetes mellitus; Antidiabetic drug; Add-on therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1723 / 1730
页数:7
相关论文
共 232 条
[1]  
Alam U(2014)General aspects of diabetes mellitus Handb Clin Neurol 126 211-222
[2]  
Asghar O(2017)IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040 Diabetes Res Clin Pract 128 40-50
[3]  
Azmi S(2016)Current status of managing diabetes mellitus in Korea The Korean Journal of Internal Medicine 31 845-850
[4]  
Malik RA(2011)2011 clinical practice guidelines for type 2 diabetes in Korea Diabetes Metab J 35 431-436
[5]  
Ogurtsova K(2017)Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus The Korean Journal of Internal Medicine 32 974-983
[6]  
da Rocha Fernandes JD(2018)Past and current status of adult type 2 diabetes mellitus management in Korea: a National Health Insurance Service database analysis Diabetes Metab J 42 93-100
[7]  
Huang Y(2017)The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: an 8-year population-based study Medicine 96 e8257-1851
[8]  
Linnenkamp U(2003)Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes Diabetes Care 26 1847-976
[9]  
Guariguata L(2009)Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis Pharmacoepidemiol Drug Saf 18 973-813
[10]  
Cho NH(2007)Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians Adv Ther 24 803-130